Viewing Study NCT00183820


Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2026-04-16 @ 8:04 PM
Study NCT ID: NCT00183820
Status: COMPLETED
Last Update Posted: 2017-07-07
First Post: 2005-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Sponsor: University of Southern California
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Testicular Cancer View
None Germ Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Testicular View
None Extra gonadal germ cell neoplasm View